Navigation Links
.decimal, Inc. Gains 510k Clearance from the FDA to Market its p.d(TM) Software for Bolus Electron Conformal Therapy in the United States
Date:5/11/2009

SANFORD, Fla., May 11 /PRNewswire/ -- .decimal, leading manufacturer of patient-specific medical devices, gains 510k clearance to release the software necessary for the delivery of Bolus Electron Conformal Therapy (Bolus ECT(TM)), an advanced form of patient-specific electron therapy. Treating with bolus ECT will be available to users of all three of the major treatment planning systems: CMS XiO(TM), Varian Eclipse(TM) and Philips Pinnacle3(TM).

(Logo: http://www.newscom.com/cgi-bin/prnh/20090203/CLTU104LOGO )

510k clearance to market the device makes it possible for cancer treatment centers in the United States to begin ordering, installing and using .decimal's propriety software, p.d, for bolus ECT. "We are now actively marketing bolus electron conformal therapy, and the response from institutions across the United States has been overwhelming as they begin to see the value to their patients through this innovative technology," says Mark Mills, Senior Vice President of Sales and Marketing at .decimal.

.decimal is the sole manufacturer of the bolus, as well as the sole software provider for bolus ECT planning.

Richard Sweat, President and CEO of the company explains, "The commercial availability of bolus electron conformal therapy is another example of our commitment to providing our customers with innovative treatment solutions and their patients with the best individualized electron treatment available in the world."

Bolus ECT can create favorable dose distributions for certain tumors of the chest wall, breast or head and neck, when a tumor volume has spread out near the patient surface and rendered other treatment problematic for a variety of reasons. Bolus ECT was first used at the University of Texas M.D. Anderson Cancer Center over ten years ago, but did not become commercially available until this software release.

"With this product we are enabling the 80% of radiation oncology facilities in the United States treating with electrons the opportunity to enhance their current electron delivery capabilities through our unique pay-as-you-go, Internet-based manufacturing business model," says Sweat.

.decimal is a medical device manufacturer of patient-specific devices, including missing tissue compensators, modulators for advanced IMRT delivery, bolus compensators for bolus electron conformal therapy, as well as apertures and range compensators used in proton therapy. The company has been providing radiation therapy products for over twenty years. For more information concerning .decimal, please see its Web site at www.dotdecimal.com.


'/>"/>
SOURCE .decimal, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. iCardiac's Highly Automated QT(sm) Technology Cross-Validated Against Results from Five Leading ECG Core Laboratories
2. Shareholder Class Action Filed Against Sequenom, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
3. Grey Ribbon Crusade(TM) Promotes National Unification in the Fight Against Brain Tumors
4. Obama Administration Rules Against Californias Proposed Wage Cuts to Homecare Workers
5. NABP Position Paper Calls for Action Against Proliferation of Rogue Internet Drug Outlets
6. Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture
7. Research opens up new horizons to the design of customized medicines against breast cancer
8. Viroblock SA Reports a 99% Boost of Efficacy of Facemasks Against H5N1
9. Oust(R) Surface Disinfectant & Air Sanitizer Effective Against H1N1
10. Federal District Judge Dismisses Antitrust Lawsuit Against Batesville Casket Company
11. Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... Park, N.C. (PRWEB) , ... March 01, 2017 ... ... collaboration to bring PurThread’s permanently embedded anti-odor solution to cotton knit and woven ... lend performance attributes while maintaining the luxurious look and feel of cotton. ...
(Date:3/1/2017)... ... March 01, 2017 , ... Breast Surgeon, Dr. Dennis Holmes ... early stage breast cancer and where it fits in the treatment paradigm at Susan ... Make .” The event brings together leading cancer and wellness experts to share the ...
(Date:3/1/2017)... ... March 01, 2017 , ... Expert on international living and leading a ... & Go. , Time & Go app is the ultimate strategic compass that helps ... time management methods enable people to work smarter, not harder, that's why Time & ...
(Date:3/1/2017)... NY & Greenwich, CT (PRWEB) , ... March 01, 2017 , ... ... runners, especially in the winter months when people don’t want to stop training to ... knees – and setting the treadmill to a small incline can help protect these ...
(Date:3/1/2017)... ... , ... “McFarnia”: a suspenseful tale of a father who vanishes without a ... disappearance. “McFarnia” is the creation of published author Tony Pierzchala, a former Army man, ... a Chaplain with Transport for Christ at a truck stop in the Greensboro area. ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... 2017 Summary This report provides ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... 2017 The presence of ... vendor landscape of the  Global Lap on Chips ... high degree of consolidation with the top 8 ... market in 2016. Among these enterprises Danaher Corporation, ... Laboratories enjoy dominance on account of extensive geographical ...
(Date:2/28/2017)... ... Research and Markets has announced the addition of the "Ovarian ... offering. The latest research Ovarian Cancer Drugs Price Analysis ... global Ovarian Cancer market. The research answers the following questions: ... Ovarian Cancer and their clinical attributes? How are they positioned in the ...
Breaking Medicine Technology: